Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWOTCMKTS:CLLKFOTCMKTS:LCDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-5.9%$0.11$0.03▼$0.37N/AN/A20,087 shs1,700 shsBBLGWBone Biologics$16.90-16.3%$20.55$3.00▼$95.04N/AN/A2,106 shs200 shsCLLKFBICO Group AB (publ)C$3.87+4.6%C$3.59C$2.59▼C$5.60N/AN/A2,030 shs1,831 shsLCDXCaliber Imaging & Diagnostics$0.00$0.00▼$0.02N/AN/A3,341 shsN/AA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos0.00%+27.97%-14.51%+0.49%+29.75%BBLGWBone Biologics0.00%-16.34%-16.34%-74.90%-23.18%CLLKFBICO Group AB (publ)0.00%+7.56%+1.37%+29.10%-13.95%LCDXCaliber Imaging & Diagnostics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/AN/AN/ALCDXCaliber Imaging & DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ACLLKFBICO Group AB (publ) 0.00N/AN/AN/ALCDXCaliber Imaging & Diagnostics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$20.73KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/ALCDXCaliber Imaging & DiagnosticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/A0.00∞N/AN/AN/AN/AN/ALCDXCaliber Imaging & DiagnosticsN/A-$0.75N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/ALCDXCaliber Imaging & DiagnosticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/ALCDXCaliber Imaging & DiagnosticsN/AInsider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/ALCDXCaliber Imaging & DiagnosticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableCLLKFBICO Group AB (publ)880N/AN/ANot OptionableLCDXCaliber Imaging & Diagnostics28N/AN/ANot OptionableCLLKF, AIMDW, BBLGW, and LCDX HeadlinesRecent News About These CompaniesStifel Nicolaus Sticks to Its Buy Rating for Caliber Imaging & Diagnostic (LCDX)February 28, 2025 | markets.businessinsider.comLCDX Caliber Imaging & Diagnostics, Inc.February 27, 2025 | seekingalpha.comCaliber Imaging & Diagnostic (LCDX) was downgraded to a Sell Rating at Bank of America SecuritiesFebruary 27, 2025 | markets.businessinsider.comCaliber Imaging & Diagnostics IncDecember 30, 2024 | morningstar.comAdvances in Diagnostic Imaging for Peripheral Arterial DiseaseFebruary 10, 2024 | medscape.comCaliber Imaging & Diagnostics, Inc. (LCDX)February 9, 2024 | nz.finance.yahoo.comCaliber Imaging & Diagnostics Inc.February 1, 2024 | wsj.comCaliber Imaging & Diagnostic (LCDX) Gets a Hold from RBC CapitalSeptember 20, 2023 | markets.businessinsider.comCaliber Imaging & Diagnostic (LCDX) Gets a Buy from Cantor FitzgeraldJuly 14, 2023 | markets.businessinsider.comCaliber Imaging & Diagnostic (LCDX) Receives a Sell from Morgan StanleyJuly 14, 2023 | markets.businessinsider.comDiagnostic Imaging Devices - South KoreaJune 27, 2023 | statista.comCTisus - Advancing Diagnostic ImagingApril 18, 2023 | medscape.comAn Update on Diagnostic Imaging Studies for Viral EncephalitisApril 17, 2023 | medscape.comDiagnostic Imaging Market 2023: Growing Opportunities by 2028March 29, 2023 | marketwatch.comDiagnostic Imaging Services Market 2023 LATEST [ R and D ] INSIGHTS in Report of 122 Pages till 2028February 26, 2023 | marketwatch.comIntroduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of KentuckiansFebruary 24, 2023 | benzinga.comIntroduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of TennesseansFebruary 22, 2023 | benzinga.comCaliber Auto Care opens new center near San Antonio Medical CenterFebruary 11, 2023 | finance.yahoo.comCaliber Home LoansJanuary 18, 2023 | consumeraffairs.comUsed 2007 Dodge Caliber for sale near meDecember 20, 2022 | cars.comMedia Sentiment Over TimeCLLKF, AIMDW, BBLGW, and LCDX Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.01 (-5.88%) As of 04/25/2025Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$16.90 -3.30 (-16.34%) As of 04/25/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.BICO Group AB (publ) OTCMKTS:CLLKFC$3.87 +0.17 (+4.59%) As of 10:26 AM EasternBICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.Caliber Imaging & Diagnostics OTCMKTS:LCDXCaliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Rebounds After Strong Earnings and Buyback Announcement Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret? The Bear Market Has Only Just Started - Here's Why MarketBeat Week in Review – 04/21 - 04/25 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy Bears Can Reap Big Benefits With These 3 Short ETF Bets Why Institutions Are Buying Super Micro Computer Stock Again Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
